<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 02 Jun 2026 06:19:26 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Leerink Starts X4 Pharmaceuticals (XFOR) at Outperform</title>
   <link>http://www.streetinsider.com/New+Coverage/Leerink+Starts+X4+Pharmaceuticals+%28XFOR%29+at+Outperform/26586568.html</link>
   <description>(Updated - June 2, 2026 6:19 AM EDT)

&lt;p&gt;Leerink initiates coverage on X4 Pharmaceuticals (NASDAQ: XFOR) with a Outperform rating and a price target of $12.00.&lt;/p&gt;&lt;p&gt;The analyst comments &quot;We are initiating coverage of X4 Pharmaceuticals (XFOR) with an Outperform rating and $12 price target, based on our positive view that lead program mavorixafor can evolve into an important rare hematology asset with blockbuster commercial potential in chronic neutropenia (CN). XFOR is a hematology-focused company anchored by mavorixafor – an oral CXCR4 antagonist already approved in the U.S. and Europe as Xolremdi for ultra-rare disease WHIM syndrome, providing important validation of the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/New+Coverage/Leerink+Starts+X4+Pharmaceuticals+%28XFOR%29+at+Outperform/26586568.html</guid>
   <pubDate>Tue, 02 Jun 2026 06:19:26 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">XFOR</category>
   	  </item>
  <item>
   <title>Leerink Starts X4 Pharmaceuticals (XFOR) at Outperform</title>
   <link>http://www.streetinsider.com/Analyst+Comments/Leerink+Starts+X4+Pharmaceuticals+%28XFOR%29+at+Outperform/26586568.html</link>
   <description>(Updated - June 2, 2026 6:19 AM EDT)

&lt;p&gt;Leerink initiates coverage on X4 Pharmaceuticals (NASDAQ: XFOR) with a Outperform rating and a price target of $12.00.&lt;/p&gt;&lt;p&gt;The analyst comments &quot;We are initiating coverage of X4 Pharmaceuticals (XFOR) with an Outperform rating and $12 price target, based on our positive view that lead program mavorixafor can evolve into an important rare hematology asset with blockbuster commercial potential in chronic neutropenia (CN). XFOR is a hematology-focused company anchored by mavorixafor – an oral CXCR4 antagonist already approved in the U.S. and Europe as Xolremdi for ultra-rare disease WHIM syndrome, providing important validation of the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/Leerink+Starts+X4+Pharmaceuticals+%28XFOR%29+at+Outperform/26586568.html</guid>
   <pubDate>Tue, 02 Jun 2026 06:19:26 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">XFOR</category>
   	  </item>
  <item>
   <title>X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</title>
   <link>http://www.streetinsider.com/Press+Releases/X4+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26584184.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;BOSTON, June  01, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=-fg0J-QuumGhaB-IwBMVV-84Hd7eXV8MZQSbZ-EkOxxdNwYqI_aQRd0P69XTllSpp956UhvEh42_ElTmlparkVQkBD5GtEVSOCqCPy-qVoQ=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;X4 Pharmaceuticals&lt;/strong&gt;&lt;/a&gt; (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced that, effective on May 29, 2026, the company issued inducement awards to new employees under the X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive Plan (the “2019 Inducement Plan”). The 2019 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of X4. The inducement awards consist of options to purchase an aggregate of 160,000 shares of X4’s common</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/X4+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26584184.html</guid>
   <pubDate>Mon, 01 Jun 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.36917942</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">XFOR</category>
   	  </item>
  <item>
   <title>X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</title>
   <link>http://www.streetinsider.com/Press+Releases/X4+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26584184.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;BOSTON, June  01, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=-fg0J-QuumGhaB-IwBMVV-84Hd7eXV8MZQSbZ-EkOxxdNwYqI_aQRd0P69XTllSpp956UhvEh42_ElTmlparkVQkBD5GtEVSOCqCPy-qVoQ=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;X4 Pharmaceuticals&lt;/strong&gt;&lt;/a&gt; (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced that, effective on May 29, 2026, the company issued inducement awards to new employees under the X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive Plan (the “2019 Inducement Plan”). The 2019 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of X4. The inducement awards consist of options to purchase an aggregate of 160,000 shares of X4’s common</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/X4+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26584184.html</guid>
   <pubDate>Mon, 01 Jun 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.36917942</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">XFOR</category>
   	  </item>
  <item>
   <title>X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</title>
   <link>http://www.streetinsider.com/Globe+Newswire/X4+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26584184.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;BOSTON, June  01, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=-fg0J-QuumGhaB-IwBMVV-84Hd7eXV8MZQSbZ-EkOxxdNwYqI_aQRd0P69XTllSpp956UhvEh42_ElTmlparkVQkBD5GtEVSOCqCPy-qVoQ=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;X4 Pharmaceuticals&lt;/strong&gt;&lt;/a&gt; (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced that, effective on May 29, 2026, the company issued inducement awards to new employees under the X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive Plan (the “2019 Inducement Plan”). The 2019 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of X4. The inducement awards consist of options to purchase an aggregate of 160,000 shares of X4’s common</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/X4+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26584184.html</guid>
   <pubDate>Mon, 01 Jun 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.36917942</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">XFOR</category>
   	  </item>
  <item>
   <title>X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</title>
   <link>http://www.streetinsider.com/Globe+Newswire/X4+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26584184.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;BOSTON, June  01, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=-fg0J-QuumGhaB-IwBMVV-84Hd7eXV8MZQSbZ-EkOxxdNwYqI_aQRd0P69XTllSpp956UhvEh42_ElTmlparkVQkBD5GtEVSOCqCPy-qVoQ=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;X4 Pharmaceuticals&lt;/strong&gt;&lt;/a&gt; (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced that, effective on May 29, 2026, the company issued inducement awards to new employees under the X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive Plan (the “2019 Inducement Plan”). The 2019 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of X4. The inducement awards consist of options to purchase an aggregate of 160,000 shares of X4’s common</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/X4+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26584184.html</guid>
   <pubDate>Mon, 01 Jun 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.36917942</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">XFOR</category>
   	  </item>
  <item>
   <title>X4 Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/X4+Pharmaceuticals+to+Present+at+the+2026+Jefferies+Global+Healthcare+Conference/26553319.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;BOSTON, May  27, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=1YemFEt6hWaypOMKnqVuabJiHhv49_-cbAt3O_nS0cOVrGComgLVB1sqpucv23r9C7gRNd27B_uj3m2jHkKQSby-borPA_ZZtj6aPAovdAU=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;X4 Pharmaceuticals&lt;/strong&gt;&lt;/a&gt; (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced that management will present at the 2026 Jefferies Global Healthcare Conference on Thursday, June 4, 2026 at 3:45 p.m. ET.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;A link to the live and archived webcast may be accessed on X4 Pharmaceuticals’ website under the Investors section: &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=hZJCWHOiaw5v_ze2PV2qzsBIrXeh0cUbSVQoYmrZZUaNSZbpTHEgl4MJQp9GD_sITOQzmAs1NntiLumh7vypdnx4MSyt9eSQ7HzLZknpbKlAz1batLaYpafBtyhHHmi9Gehg4QF_kFn-aWouHI96fw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Events and Presentations&lt;/a&gt;.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;About X4 Pharmaceuticals&lt;/strong&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;X4 Pharmaceuticals is a company focused on improving the lives of people</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/X4+Pharmaceuticals+to+Present+at+the+2026+Jefferies+Global+Healthcare+Conference/26553319.html</guid>
   <pubDate>Wed, 27 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.36917942</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">XFOR</category>
   	  </item>
  <item>
   <title>X4 Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/X4+Pharmaceuticals+to+Present+at+the+2026+Jefferies+Global+Healthcare+Conference/26553319.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;BOSTON, May  27, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=1YemFEt6hWaypOMKnqVuabJiHhv49_-cbAt3O_nS0cOVrGComgLVB1sqpucv23r9C7gRNd27B_uj3m2jHkKQSby-borPA_ZZtj6aPAovdAU=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;X4 Pharmaceuticals&lt;/strong&gt;&lt;/a&gt; (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced that management will present at the 2026 Jefferies Global Healthcare Conference on Thursday, June 4, 2026 at 3:45 p.m. ET.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;A link to the live and archived webcast may be accessed on X4 Pharmaceuticals’ website under the Investors section: &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=hZJCWHOiaw5v_ze2PV2qzsBIrXeh0cUbSVQoYmrZZUaNSZbpTHEgl4MJQp9GD_sITOQzmAs1NntiLumh7vypdnx4MSyt9eSQ7HzLZknpbKlAz1batLaYpafBtyhHHmi9Gehg4QF_kFn-aWouHI96fw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Events and Presentations&lt;/a&gt;.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;About X4 Pharmaceuticals&lt;/strong&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;X4 Pharmaceuticals is a company focused on improving the lives of people</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/X4+Pharmaceuticals+to+Present+at+the+2026+Jefferies+Global+Healthcare+Conference/26553319.html</guid>
   <pubDate>Wed, 27 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.36917942</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">XFOR</category>
   	  </item>
  <item>
   <title>X4 Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference</title>
   <link>http://www.streetinsider.com/Globe+Newswire/X4+Pharmaceuticals+to+Present+at+the+2026+Jefferies+Global+Healthcare+Conference/26553319.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;BOSTON, May  27, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=1YemFEt6hWaypOMKnqVuabJiHhv49_-cbAt3O_nS0cOVrGComgLVB1sqpucv23r9C7gRNd27B_uj3m2jHkKQSby-borPA_ZZtj6aPAovdAU=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;X4 Pharmaceuticals&lt;/strong&gt;&lt;/a&gt; (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced that management will present at the 2026 Jefferies Global Healthcare Conference on Thursday, June 4, 2026 at 3:45 p.m. ET.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;A link to the live and archived webcast may be accessed on X4 Pharmaceuticals’ website under the Investors section: &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=hZJCWHOiaw5v_ze2PV2qzsBIrXeh0cUbSVQoYmrZZUaNSZbpTHEgl4MJQp9GD_sITOQzmAs1NntiLumh7vypdnx4MSyt9eSQ7HzLZknpbKlAz1batLaYpafBtyhHHmi9Gehg4QF_kFn-aWouHI96fw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Events and Presentations&lt;/a&gt;.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;About X4 Pharmaceuticals&lt;/strong&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;X4 Pharmaceuticals is a company focused on improving the lives of people</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/X4+Pharmaceuticals+to+Present+at+the+2026+Jefferies+Global+Healthcare+Conference/26553319.html</guid>
   <pubDate>Wed, 27 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.36917942</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">XFOR</category>
   	  </item>
  <item>
   <title>X4 Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference</title>
   <link>http://www.streetinsider.com/Globe+Newswire/X4+Pharmaceuticals+to+Present+at+the+2026+Jefferies+Global+Healthcare+Conference/26553319.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;BOSTON, May  27, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=1YemFEt6hWaypOMKnqVuabJiHhv49_-cbAt3O_nS0cOVrGComgLVB1sqpucv23r9C7gRNd27B_uj3m2jHkKQSby-borPA_ZZtj6aPAovdAU=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;X4 Pharmaceuticals&lt;/strong&gt;&lt;/a&gt; (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced that management will present at the 2026 Jefferies Global Healthcare Conference on Thursday, June 4, 2026 at 3:45 p.m. ET.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;A link to the live and archived webcast may be accessed on X4 Pharmaceuticals’ website under the Investors section: &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=hZJCWHOiaw5v_ze2PV2qzsBIrXeh0cUbSVQoYmrZZUaNSZbpTHEgl4MJQp9GD_sITOQzmAs1NntiLumh7vypdnx4MSyt9eSQ7HzLZknpbKlAz1batLaYpafBtyhHHmi9Gehg4QF_kFn-aWouHI96fw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Events and Presentations&lt;/a&gt;.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;About X4 Pharmaceuticals&lt;/strong&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;X4 Pharmaceuticals is a company focused on improving the lives of people</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/X4+Pharmaceuticals+to+Present+at+the+2026+Jefferies+Global+Healthcare+Conference/26553319.html</guid>
   <pubDate>Wed, 27 May 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.36917942</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">XFOR</category>
   	  </item>
  <item>
   <title>Form  EFFECT     X4 Pharmaceuticals, Inc              </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++X4+Pharmaceuticals%2C+Inc++++++++++++++/26509675.html</link>
   <description>si-local-file:///var/storage/secattach/20260518/26509675.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++X4+Pharmaceuticals%2C+Inc++++++++++++++/26509675.html</guid>
   <pubDate>Mon, 18 May 2026 06:04:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.36917942</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">XFOR</category>
   	  </item>
  <item>
   <title>Form  EFFECT     X4 Pharmaceuticals, Inc              </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++X4+Pharmaceuticals%2C+Inc++++++++++++++/26509675.html</link>
   <description>si-local-file:///var/storage/secattach/20260518/26509675.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++X4+Pharmaceuticals%2C+Inc++++++++++++++/26509675.html</guid>
   <pubDate>Mon, 18 May 2026 06:04:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.36917942</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">XFOR</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  X4 Pharmaceuticals, Inc                Filed by: PERCEPTIVE ADVISORS LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++X4+Pharmaceuticals%2C+Inc++++++++++++++++Filed+by%3A+PERCEPTIVE+ADVISORS+LLC/26504602.html</link>
   <description>si-local-file:///var/storage/secattach/20260515/26504602.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++X4+Pharmaceuticals%2C+Inc++++++++++++++++Filed+by%3A+PERCEPTIVE+ADVISORS+LLC/26504602.html</guid>
   <pubDate>Fri, 15 May 2026 16:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.36917942</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">XFOR</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  X4 Pharmaceuticals, Inc                Filed by: PERCEPTIVE ADVISORS LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++X4+Pharmaceuticals%2C+Inc++++++++++++++++Filed+by%3A+PERCEPTIVE+ADVISORS+LLC/26504602.html</link>
   <description>si-local-file:///var/storage/secattach/20260515/26504602.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++X4+Pharmaceuticals%2C+Inc++++++++++++++++Filed+by%3A+PERCEPTIVE+ADVISORS+LLC/26504602.html</guid>
   <pubDate>Fri, 15 May 2026 16:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.36917942</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">XFOR</category>
   	  </item>
  <item>
   <title>Form  8-K/A      X4 Pharmaceuticals, Inc   For: May 11</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++X4+Pharmaceuticals%2C+Inc+++For%3A+May+11/26487229.html</link>
   <description>si-local-file:///var/storage/secattach/20260513/26487229.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++X4+Pharmaceuticals%2C+Inc+++For%3A+May+11/26487229.html</guid>
   <pubDate>Wed, 13 May 2026 16:58:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.36917942</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">XFOR</category>
   	  </item>
  <item>
   <title>Form  8-K/A      X4 Pharmaceuticals, Inc   For: May 11</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++X4+Pharmaceuticals%2C+Inc+++For%3A+May+11/26487229.html</link>
   <description>si-local-file:///var/storage/secattach/20260513/26487229.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++X4+Pharmaceuticals%2C+Inc+++For%3A+May+11/26487229.html</guid>
   <pubDate>Wed, 13 May 2026 16:58:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.36917942</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">XFOR</category>
   	  </item>
  <item>
   <title>Form  4          X4 Pharmaceuticals, Inc   For: May 12  Filed by: KIRSKE DAVID</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++X4+Pharmaceuticals%2C+Inc+++For%3A+May+12++Filed+by%3A+KIRSKE+DAVID/26485744.html</link>
   <description>si-local-file:///var/storage/secattach/20260513/26485744.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++X4+Pharmaceuticals%2C+Inc+++For%3A+May+12++Filed+by%3A+KIRSKE+DAVID/26485744.html</guid>
   <pubDate>Wed, 13 May 2026 16:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.36917942</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">XFOR</category>
   	  </item>
  <item>
   <title>Form  4          X4 Pharmaceuticals, Inc   For: May 12  Filed by: KIRSKE DAVID</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++X4+Pharmaceuticals%2C+Inc+++For%3A+May+12++Filed+by%3A+KIRSKE+DAVID/26485744.html</link>
   <description>si-local-file:///var/storage/secattach/20260513/26485744.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++X4+Pharmaceuticals%2C+Inc+++For%3A+May+12++Filed+by%3A+KIRSKE+DAVID/26485744.html</guid>
   <pubDate>Wed, 13 May 2026 16:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.36917942</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">XFOR</category>
   	  </item>
  <item>
   <title>Form  144        X4 Pharmaceuticals, Inc                Filed by: KIRSKE DAVID</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++X4+Pharmaceuticals%2C+Inc++++++++++++++++Filed+by%3A+KIRSKE+DAVID/26479696.html</link>
   <description>si-local-file:///var/storage/secattach/20260512/26479696.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++X4+Pharmaceuticals%2C+Inc++++++++++++++++Filed+by%3A+KIRSKE+DAVID/26479696.html</guid>
   <pubDate>Tue, 12 May 2026 18:11:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.36917942</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">XFOR</category>
   	  </item>
  <item>
   <title>Form  144        X4 Pharmaceuticals, Inc                Filed by: KIRSKE DAVID</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++X4+Pharmaceuticals%2C+Inc++++++++++++++++Filed+by%3A+KIRSKE+DAVID/26479696.html</link>
   <description>si-local-file:///var/storage/secattach/20260512/26479696.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++X4+Pharmaceuticals%2C+Inc++++++++++++++++Filed+by%3A+KIRSKE+DAVID/26479696.html</guid>
   <pubDate>Tue, 12 May 2026 18:11:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.36917942</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">XFOR</category>
   	  </item>
  <item>
   <title>Form  8-K        X4 Pharmaceuticals, Inc   For: May 11</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++X4+Pharmaceuticals%2C+Inc+++For%3A+May+11/26478325.html</link>
   <description>si-local-file:///var/storage/secattach/20260512/26478325.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++X4+Pharmaceuticals%2C+Inc+++For%3A+May+11/26478325.html</guid>
   <pubDate>Tue, 12 May 2026 16:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.36917942</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">XFOR</category>
   	  </item>
  <item>
   <title>Form  8-K        X4 Pharmaceuticals, Inc   For: May 11</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++X4+Pharmaceuticals%2C+Inc+++For%3A+May+11/26478325.html</link>
   <description>si-local-file:///var/storage/secattach/20260512/26478325.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++X4+Pharmaceuticals%2C+Inc+++For%3A+May+11/26478325.html</guid>
   <pubDate>Tue, 12 May 2026 16:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.36917942</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">XFOR</category>
   	  </item>
  <item>
   <title>X4 Pharmaceuticals (XFOR) Misses Q1 EPS by 16c</title>
   <link>http://www.streetinsider.com/Earnings/X4+Pharmaceuticals+%28XFOR%29+Misses+Q1+EPS+by+16c/26447144.html</link>
   <description>&lt;p&gt;X4 Pharmaceuticals (NASDAQ: XFOR) reported Q1 EPS of ($0.16). Revenue for the quarter came in at $2.71 million.&lt;/p&gt;&lt;p&gt;For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) &lt;a href=&quot;http://www.streetinsider.com/ec_earnings.php?q=XFOR&quot;&gt;click here&lt;/a&gt;.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Earnings/X4+Pharmaceuticals+%28XFOR%29+Misses+Q1+EPS+by+16c/26447144.html</guid>
   <pubDate>Thu, 07 May 2026 06:05:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">XFOR</category>
   	  </item>
  <item>
   <title>Form  S-3        X4 Pharmaceuticals, Inc              </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++X4+Pharmaceuticals%2C+Inc++++++++++++++/26443791.html</link>
   <description>si-local-file:///var/storage/secattach/20260506/26443791.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++X4+Pharmaceuticals%2C+Inc++++++++++++++/26443791.html</guid>
   <pubDate>Wed, 06 May 2026 16:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.36917942</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">XFOR</category>
   	  </item>
  <item>
   <title>Form  S-3        X4 Pharmaceuticals, Inc              </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++X4+Pharmaceuticals%2C+Inc++++++++++++++/26443791.html</link>
   <description>si-local-file:///var/storage/secattach/20260506/26443791.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++X4+Pharmaceuticals%2C+Inc++++++++++++++/26443791.html</guid>
   <pubDate>Wed, 06 May 2026 16:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.36917942</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">XFOR</category>
   	  </item>
 </channel>
</rss>
